Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

ale following approval. We have also designed the facility to be used as a contract manufacturing facility during those times (e.g., during certain times in the Phase III study) when we will not be producing Multikine. This lucrative business could quickly become a multi-million dollar revenue generator for CEL-SCI.

  • We presented very promising data on a new rheumatoid arthritis vaccine discovered by CEL-SCI scientists. The data presented was as good as that achieved with Enbrel, a leading treatment for rheumatoid arthritis.

  • We started planning and pricing our global clinical trial designed to lead to marketing approval for Multikine. The recent strength of the dollar will reduce our Phase III study costs by several million dollars.

While we are pleased by these accomplishments, we also recognize that there are major challenges due to the severe financial downturn. This downturn has affected all of us, but we have taken immediate action. We very quickly reduced our expenditures and expanded our discussions with various pharmaceutical companies for a world-wide Multikine partnership. Things are very difficult all around for most companies, but we are seeing new strength in the bigger biotechnology names. This will hopefully trickle down to the smaller ones like us as well. The huge buyouts in the industry, Pfizer buying Wyeth and Roche trying to buy Genentech, will add over $100 billion in liquidity to the industry, and that too should help us down the road.

Let me share with you how we at CEL-SCI are dealing with and planning for recovery from this financial downturn. In our opinion, during such a difficult time as this you cannot rely on one strategy alone. Therefore we are pursuing the following multi-pronged strategy. To
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Inc. (NASDAQ: UPI ), a medical device company ... treat voiding dysfunctions, today announced that it will participate ... 10, 2015. Rob Kill , President and CEO, ... present at 4:00 p.m. Pacific Time and meet with ... Ritz Carlton in Laguna Niguel, CA. ...
(Date:2/27/2015)... , Feb. 27, 2015  Two mass ... in applications as their effectiveness is established, ... Information.  Kalorama Information says that while mass ... most powerful tool in proteomic biomarker discovery ... through its traditional techniques has struggled to ...
(Date:2/26/2015)... Feb. 26, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... 5,250,000 shares of its common stock at a price ... proceeds to Tandem from this offering are expected to ... and other estimated offering expenses payable by Tandem. All ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... April 5, 2011 Healthpoint Biotherapeutics today announced ... Reciprocity in the Wound Microenvironment , has been ... and Regeneration. The manuscript authors–Drs. Gregory Schultz, Jeffrey ... members of the Dynamic Reciprocity Work Group (DRWG), ...
... April 5, 2011 Par Pharmaceutical Companies, Inc. (NYSE: ... conference call and live webcast on Thursday, May 5, 2011 ... quarter 2011.  Par will release its financial results on May ... the live webcast can be made via the Company,s website ...
Cached Medicine Technology:Dynamic Reciprocity Examined as Scientific Framework for Wound Healing in March/April Issue of Wound Repair and Regeneration 2Dynamic Reciprocity Examined as Scientific Framework for Wound Healing in March/April Issue of Wound Repair and Regeneration 3Dynamic Reciprocity Examined as Scientific Framework for Wound Healing in March/April Issue of Wound Repair and Regeneration 4Dynamic Reciprocity Examined as Scientific Framework for Wound Healing in March/April Issue of Wound Repair and Regeneration 5
(Date:2/27/2015)... CO (PRWEB) February 27, 2015 Philanthropy is ... Kevin and Amy Smits help to restore that faith ... the last six years, this husband/wife Realtor team gives to ... charities have remained the same while others have been added ... Assault provides a safe haven and counseling for women ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The report ... trends in the global celiac disease market. It also ... research and development activities, and investments. , Celiac disease ... gluten damages the small intestine. Celiac disease often has ... every 100 people is affected by celiac disease across ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 UAS LifeSciences, ... Cubes, at Natural Products Expo West, March 6 to ... very excited to release the hands down best tasting ... taste with an extra zing of Vitamin C. This ... winner of the NutrAward 2014, Delicious Living’s Supplement Award ...
(Date:2/27/2015)... The Willliams Companies Inc owns and ... Wyoming. The plant processes natural gas gathered from ... gas pipeline transport. It also produces natural gas liquids ... began operations in 1958, and in recent decades has ... in Wyoming. The plant currently has approximately 40 ...
(Date:2/27/2015)... February 27, 2015 The Connecticut Community ... excellence, along with Alcohol and Drug Recovery Centers (ADRC), ... Together, these organizations were honored with the 2014 Commissioner’s ... and Addiction Services. Last year, ROES achieved ... assist people who are recovering from alcoholism and other ...
Breaking Medicine News(10 mins):Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... Ghanshyam Sarda, a prime accused in the expired blood ... senior police official.// ,"We have arrested Ghanshyam ... in court," said Gyanwant Singh, deputy commissioner of police ... was arrested a few days ago. The brothers own ...
... Scientists have identified a naturally occurring enzyme that can ... characteristic of Alzheimer's disease.// The finding may provide researchers ... the brains of Alzheimer's patients and could one day ... University School of Medicine in St. Louis showed earlier ...
... flu vaccine are not as effective as all the hype ... author Dr. Tom Jefferson, coordinator of the Cochrane Vaccines Field ... what vaccines can actually do. I'm hoping American and European ... ,The findings of the study have been published in the ...
... A study assessing a new asthma inhaler revealed that it has ... in 2005 to stop// the funding for Ventolin inhalers in favour ... Salamol inhaler were observed. Only 15 of them were able to ... ineffectiveness of the drug or due to the taste. Asthma stability ...
... for protection against Alzheimer's disease is to be resumed and ... the initial trial. ,The progress of the disease was ... beta amyloid protein causing the disease. But during the second ... of brain inflammation and the study was brought to a ...
... for treatment of obesity, has been found to control blood sugar ... 2. The research was done on 1,047 overweight or obese patients ... ,Some of them were given 5 or 20 mg/day ... a 1 year period. Those on the drug showed a vast ...
Cached Medicine News:Health News:Naturally Occurring Enzyme Can Break Down Key Part of Alzheimer's Plaques 2Health News:Flu Shots-Do we Really Need Them? 2Health News:Alzheimer's Vaccine- A Realistic Prospect 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: